Signalling loops and linear pathways: NF-κB activation in response to genotoxic stress

Mutagenesis

Volumn 24, Issue 1, 2009, Pages 1-8

  Brzóska, Kamil ^a   Szumiel, Irena ^a  

^a INSTITUTE OF NUCLEAR CHEMISTRY AND TECHNOLOGY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; CAMPTOTHECIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHOSPHOTRANSFERASE; PROTEIN P53; REACTIVE OXYGEN METABOLITE;

ATAXIA TELANGIECTASIA; CELL MEMBRANE; CELL NUCLEUS; CYTOPLASM; DNA DAMAGE; DOUBLE STRANDED DNA BREAK; ENZYME ACTIVATION; GENE MUTATION; GENOTOXICITY; HUMAN; IONIZING RADIATION; PRIORITY JOURNAL; PROTEIN TRANSPORT; REVIEW; SIGNAL TRANSDUCTION;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; CARRIER PROTEINS; CELL CYCLE PROTEINS; CELL NUCLEUS; DNA BREAKS, DOUBLE-STRANDED; DNA DAMAGE; DNA-BINDING PROTEINS; HUMANS; MICE; NF-KAPPA B; PROTEIN-SERINE-THREONINE KINASES; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEINS;

ATAXIA TELANGIECTASIA;

EID: 58149109907     PISSN: 02678357     EISSN: 14643804     Source Type: Journal    
DOI: 10.1093/mutage/gen056     Document Type: Review

References (65)

1. Weichselbaum, R. R., Hallahan, D. E., Sukhatme, V., Dritschilo, A., Sherman, M. L. and Kufe, D. W. (1991) Biological consequences of gene regulation after ionizing radiation exposure. J. Natl. Cancer Inst., 83, 480-484.
2. Wojewódzka, M., Walicka, M., Sochanowicz, B. and Szumiel, I. (1994) Calcium antagonist, TMB-8, prevents the induction of adaptive response by hydrogen peroxide or X-rays in human lymphocytes. Int. J. Radiat. Biol., 66, 99-109.
3. Wojewódzka, M., Kruszewski, M. and Szumiel, I. (1996) Anti-CD38 prevents the development of the adaptive response induced by X-rays in human lymphocytes. Mutagenesis, 11, 593-596.
4. Wojewódzka, M., Kruszewski, M. and Szumiel, I. (1997) Effect of signal transduction inhibition in adapted lymphocytes: micronuclei frequency and DNA repair. Int. J. Radiat. Biol., 71, 245-252.
5. Olivieri, G., Bodycote, J. and Wolff, S. (1984) Adaptive response of human lymphocytes to low concentrations of radioactive thymidine. Science, 223, 594-597.
6. Sanchez, P., De Carcer, G., Sandoval, I. V., Moscat, J. and Diaz-Meco, M. T. (1998) Localization of atypical protein kinase C isoforms into lysosome-targeted endosomes through interaction with p62. Mol. Cell. Biol., 18, 3069-3080.
7. Knebel, A., Rahmsdorf, H. J., Ullrich, A. and Herrlich, P. (1996) Dephosphorylation of receptor tyrosine kinases as target of regulation by radiation, oxidants or alkylating agents. EMBO J., 15, 5314-5325.
8. Abdelmohsen, K., Gerber, P. A., von Montfort, C., Sies, H. and Klotz, L. O. (2003) Epidermal growth factor receptor is a common mediator of quinone-induced signaling leading to phosphorylation of connexin-43: role of glutathione and tyrosine phosphatases. J. Biol. Chem., 278, 38360-38367.
9. Kamata, H., Honda, S., Maeda, S., Chang, L., Hirata, H. and Karin, M. (2005) Reactive oxygen species promote TNFalpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell, 120, 649-661.
10. Salmeen, A. and Barford, D. (2005) Functions and mechanisms of redox regulation of cysteine-based phosphatases. Antioxid. Redox. Signal., 7, 560-577.
11. Stoker, A. W. (2005) Protein tyrosine phosphatases and signalling. J. Endocrinol., 185, 19-33.
12. Piret, B. and Piette, J. (1996) Topoisomerase poisons activate the transcription factor NF-kappaB in ACH-2 and CEM cells. Nucleic Acids Res., 24, 4242-4248.
13. Huang, T. T., Wuerzberger-Davis, S. M., Seufzer, B. J., Shumway, S. D., Kurama, T., Boothman, D. A. and Miyamoto, S. (2000) NF-kappaB activation by camptothecin. A linkage between nuclear DNA damage and cytoplasmic signaling events. J. Biol. Chem., 275, 9501-9509.
14. Hayden, M. S. and Ghosh, S. (2008) Shared principles in NF-kappaB signaling. Cell, 132, 344-362.
15. Sarkar, F. H. and Li, Y. (2008) NF-kappaB: a potential target for cancer chemoprevention and therapy. Front. Biosci., 13, 2950-2959.
16. Ahn, K. S., Sethi, G. and Aggarwal, B. B. (2007) Nuclear factor-kappa B: from clone to clinic. Curr. Mol. Med., 7, 619-637.
17. Ahmed, K. M. and Li, J. J. (2007) ATM-NF-kappaB connection as a target for tumor radiosensitization. Curr. Cancer Drug Targets, 7, 335-342.
18. Ahmed, K. M. and Li, J. J. (2008) NF-kappa B-mediated adaptive resistance to ionizing radiation. Free. Radic. Biol. Med., 44, 1-13.
19. Janssens, S. and Tschopp, J. (2006) Signals from within: the DNA-damage-induced NF-kappaB response. Cell Death Differ., 13, 773-784.
20. Janssens, S., Tinel, A., Lippens, S. and Tschopp, J. (2005) PIDD mediates NF-kappaB activation in response to DNA damage. Cell, 123, 1079-1092.
21. Wu, Z. H. and Miyamoto, S. (2007) Many faces of NF-kappaB signaling induced by genotoxic stress. J. Mol. Med., 85, 1187-1202.
22. Wu, Z. H., Mabb, A. and Miyamoto, S. (2005) PIDD: a switch hitter. Cell, 123, 980-982.
23. Mabb, A. M., Wuerzberger-Davis, S. M. and Miyamoto, S. (2006) PIASy mediates NEMO sumoylation and NF-kappaB activation in response to genotoxic stress. Nat. Cell. Biol., 8, 986-993.
24. Perkins, N. D. (2007) Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat. Rev. Mol. Cell. Biol., 8, 49-62.
25. Bakkenist, C. J. and Kastan, M. B. (2003) DNA damage activates ATM through intermolecular autophosphorylation and dimmer dissociation. Nature, 421, 499-506.
26. Lee, J. H. and Paull, T. T. (2005) ATM activation by DNA double-strand breaks through the Mre11-Rad50-NBS complex. Science, 308, 551-554.
27. Lee, S. J., Dimtchev, A., Lavin, M. F., Dritschilo, A. and Jung, M. (1998) A novel ionizing radiation-induced signaling pathway that activates the transcription factor NF-kappaB. Oncogene, 17, 1821-1826.
28. He, L., Kim, B. Y., Kim, K. A. et al. (2007) NF-kappaB inhibition enhances caspase-3 degradation of Akt1 and apoptosis in response to camptothecin. Cell. Signal., 19, 1713-1721.
29. Bilyeu, J. D., Panta, G. R., Cavin, L. G., Barrett, C. M., Turner, E. J., Sweatman, T. W., Israel, M., Lothstein, L. and Arsura, M. (2004) Circumvention of nuclear factor kappaB-induced chemoresistance by cytoplasmic-targeted anthracyclines. Mol. Pharmacol., 65, 1038-1047.
30. Kastan, M. B. and Lim, D. S. (2000) The many substrates and functions of ATM. Nat. Rev. Mol. Cell Biol., 1, 179-186.
31. Lin, Y., Ma, W. and Benchimol, S. (2000) Pidd, a new death-domain- containing protein, is induced by p53 and promotes apoptosis. Nat. Genet., 26, 122-127.
32. Piret, B., Schoonbroodt, S. and Piette, J. (1999) The ATM protein is required for sustained activation of NF-kappaB following DNA damage. Oncogene, 18, 2261-2271.
33. Berchtold, C. M., Wu, Z. H., Huang, T. T. and Miyamoto, S. (2007) Calcium-dependent regulation of NEMO nuclear export in response to genotoxic stimuli. Mol. Cell. Biol., 27, 497-509.
34. Chen, L. F. and Greene, W. C. (2004) Shaping the nuclear action of NF-kappaB. Nat. Rev. Mol. Cell Biol., 5, 392-401.
35. Basu, S., Rosenzweig, K. R., Youmell, M. and Price, B. D. (1998) The DNA-dependent protein kinase participates in the activation of NF kappa B following DNA damage. Biochem. Biophys. Res. Commun., 247, 79-83.
36. Panta, G. R., Kaur, S., Cavin, L. G., Cortés, M. L., Mercurio, F., Lothstein, L., Sweatman, T. W., Israel, M. and Arsura, M. (2004) ATM and the catalytic subunit of DNA-dependent protein kinase activate NF-kappaB through a common MEK/extracellular signal-regulated kinase/p90(rsk) signalling pathway in response to distinct forms of DNA damage. Mol. Cell. Biol., 24, 1823-1835.
37. Liu, L., Kwak, Y. T., Bex, F., García-Martínez, L. F., Li, X. H., Meek, K., Lane, W. S. and Gaynor, R. B. (1998) DNA-dependent protein kinase phosphorylation of IkappaB alpha and IkappaB beta regulates NF-kappaB DNA binding properties. Mol. Cell. Biol., 18, 4221-4234.
38. Ravi, D., Muniyappa, H. and Das, K. C. (2008) Caffeine inhibits UVmediated NF-kappaB activation in A2058 melanoma cells: an ATM-PKCdelta-p38 MAPK-dependent mechanism. Mol. Cell. Biochem., 308, 193-200.
39. Tinel, A., Janssens, S., Lippens, S., Cuenin, S., Logette, E., Jaccard, B., Quadroni, M. and Tschopp, J. (2007) Autoproteolysis of PIDD marks the bifurcation between pro-death caspase-2 and pro-survival NF-kappaB pathway. EMBO J., 26, 197-208.
40. Cuenin, S., Tinel, A., Janssens, S. and Tschopp, J. (2008) p53-induced protein with a death domain (PIDD) isoforms differentially activate nuclear factor-kappaB and caspase-2 in response to genotoxic stress. Oncogene, 27, 387-396.
41. Hur, G. M., Lewis, J., Yang, Q., Lin, Y., Nakano, H., Nedospasov, S. and Liu, Z. G. (2003) The death domain kinase RIP has an essential role in DNA damage-induced NF-kappaB activation. Genes Dev., 17, 873-882.
42. Tinel, A. and Tschopp, J. (2004) The PIDDosome, a protein complex implicated in activation of caspase-2 in response to genotoxic stress. Science, 304, 843-846.
43. Rashi-Elkeles, S., Elkon, R., Weizman, N. et al. (2006) Parallel induction of ATM-dependent pro- and antiapoptotic signals in response to ionizing radiation in murine lymphoid tissue. Oncogene, 25, 1584-1592.
44. Elkon, R., Rashi-Elkeles, S., Lerenthal, Y., Linhart, C., Tenne, T., Amariglio, N., Rechavi, G., Shamir, R. and Shiloh, Y. (2005) Dissection of a DNA-damage-induced transcriptional network using a combination of microarrays, RNA interference and computational promoter analysis. Genome Biol., 6, R43.
45. Aylon, Y. and Oren, M. (2007) Living with p53, dying of p53. Cell, 130, 597-600.
46. Vousden, K. H. (2006) Outcomes of p53 activation-spoilt for choice. J. Cell Sci., 119, 5015-5020.
47. Kuribayashi, K. and El-Deiry, W. S. (2008) Regulation of programmed cell death by the p53 pathway. Adv. Exp. Med. Biol., 615, 201-221.
48. Chen, F., Bower, J., Leonard, S. S. et al. (2002) Protective roles of NF-kappa B for chromium(VI)-induced cytotoxicity is revealed by expression of Ikappa B kinase-beta mutant. J. Biol. Chem., 277, 3342-3349.
49. Ha, L., Ceryak, S. and Patierno, S. R. (2004) Generation of S phase-dependent DNA double-strand breaks by Cr(VI) exposure: involvement of ATM in Cr(VI) induction of gamma-H2AX. Carcinogenesis, 25, 2265-2274.
50. Lee, A. J., Hodges, N. J. and Chipman, J. K. (2004) Modified comet assay as a biomarker of sodium dichromate-induced oxidative DNA damage: optimization and reproducibility. Biomarkers, 9, 103-115.
51. Dejardin, E. (2006) The alternative NF-kB pathway from biochemistry to biology: pitfalls and promises for future drug development. Biochem. Pharmacol., 72, 1161-1179.
52. Li, Q. and Engelhardt, J. F. (2006) Interleukin-1beta induction of NFkappaB is partially regulated by H2O2-mediated activation of NFkappaB-inducing kinase. J. Biol. Chem., 281, 1495-1505.
53. Hayakawa, M., Miyashita, H., Sakamoto, I., Kitagawa, M., Tanaka, H., Yasuda, H., Karin, M. and Kikugawa, K. (2003) Evidence that reactive oxygen species do not mediate NF-kappaB activation. EMBO J., 22, 3356-3366.
54. Shen, H.-M. and Pervaiz, S. (2006) TNF receptor superfamily-induced cell death: redox-dependent execution. FASEB J., 20, 1589-1598.
55. Nakano, H., Shindo, M., Sakon, S., Nishinaka, S., Mihara, M., Yagita, H. and Okumura, K. (1998) Differential regulation of IkappaB kinase alpha and beta by two upstream kinases, NF-kappaB-inducing kinase and mitogen-activated protein kinase/ERK kinase kinase-1. Proc. Natl. Acad. Sci. USA., 95, 3537-3542.
56. Zhou, D., Yu, T., Chen, G., Brown, S. A., Yu, Z., Mattson, M. P. and Thompson, J. S. (2001) Effects of NF-kappaB1 (p50) targeted gene disruption on ionizing radiation-induced NF-kappaB activation and TNFalpha, IL-1alpha, IL-1beta and IL-6 mRNA expression in vivo. Int. J. Radiat. Biol., 77, 763-772.
57. Baptiste-Okoh, N., Barsotti, A. M. and Prives, C. (2008) A role for caspase 2 and PIDD in the process of p53-mediated apoptosis. Proc. Natl. Acad. Sci. USA., 105, 1937-1942.
58. Ricci, J. E., Munoz-Pinedo, C., Fitzgerald, P., Bailly-Maitre, B., Perkins, G. A., Yadava, N., Scheffler, I. E., Ellisman, M. H. and Green, D. R. (2004) Disruption of mitochondrial function during apoptosis is mediated by caspase cleavage of the p75 subunit of complex I of the electron transport chain. Cell, 117, 773-786.
59. Reelfs, O., Tyrrell, R. M. and Pourzand, C. (2004) Ultraviolet a radiation-induced immediate iron release is a key modulator of the activation of NF-kappaB in human skin fibroblasts. J. Invest. Dermatol., 122, 1440-1447.
60. Zhengquan, Y., Persson, H., Eaton, J. and Brunk, U. (2003) Intralysosomal iron: a major determinant of oxidant-induced cell death. Free Radic. Biol. Med., 34, 1243-1252.
61. Tenopoulou, M., Doulias, P. T., Barbouti, A., Brunk, U. and Galaris, D. (2005) Role of compartmentalized redox-active iron in hydrogen peroxide-induced DNA damage and apoptosis. Biochem. J., 387, 703-710.
62. Kim, H. J., Hawke, N. and Baldwin, A. S. (2006) NF-kappaB and IKK as therapeutic targets in cancer. Cell Death Differ., 13, 738-747.
63. Luo, J. L., Kamata, H. and Karin, M. (2005) IKK/NF-kappaB signaling: balancing life and death - a new approach to cancer therapy. J. Clin. Invest., 115, 2625-2632.
64. Greten, F. R. and Karin, M. (2004) The IKK/NF-kappaB activation pathway - a target for prevention and treatment of cancer. Cancer Lett., 206, 193-199.
65. Burdelya, L. G., Krivokrysenko, V. I., Tallant, T. C. et al. (2008) An agonist of toll-like receptor 5 has radioprotective activity in mouse and primate models. Science, 320, 226-230.